A Genetically Engineered Primary Human Natural Killer Cell Platform for Cancer Immunotherapy

Pomeroy, E. J., Hunzeker, J. T., Kluesner, M. G., Lahr, W. S., Smeester, B. A., Crosby, M. R., Lonetree, C., Yamamoto, K., Bendzick, L., Miller, J. S., Geller, M. A., Walcheck, B., Felices, M., Webber, B. R., Starr, T. K., Moriarity, B. S.  A Genetically Engineered Primary Human Natural Killer Cell Platform for Cancer Immunotherapy.  Molecular Therapy. 2020; 28(1), 52-63.  doi:10.1016/j.ymthe.2019.10.009

Date

BioLife Solutions Symbol

This website uses cookies to ensure you get the best experience on our website.